Abstract
In an attempt to refine the H-bond-mediated Aglycone Delivery (HAD) glycosylation reaction reported herein is the synthesis of β-glucosides using an ethylthio glucoside donor equipped with the remote 6-O-picoloyl substituent. Upon examining various aliphatic, aromatic, and carbohydrate acceptors, it was determined that both electronic and steric factors may greatly affect the stereoselectivity of the HAD reaction with this donor.
Keywords: synthesis, stereoselectivity, glycosylation, oligosaccharides
Graphical Abstract

Introduction
The chemical synthesis of glycans still faces many challenges and the biggest and most common problem is chemical glycosylation, the reaction of joining saccharide units via O-glycosidic linkages.1-3 Due to the inherited mechanistic nature of this reaction, stereocontrol is often difficult to achieve.4,5 This results in the formation of undesired diastereomers, lowering yields and complicating purification. There are various conditions and methods currently used to control stereoselectivity.6,7 Among these is the hydrogen-bond-mediated aglycone delivery (HAD) method. First reported in 2012,8 the HAD method employs a glycosyl donor functionalized with a picoloyl (Pico) or similar moiety, a hydrogen bond accepting protecting group. This picoloyl group forms a hydrogen bond with the free hydroxyl of the glycosyl acceptor, forming an H-bonded donor-acceptor complex (Scheme 1). After addition of the promoter, the donor is activated without disrupting the H-bonded complex, and the acceptor is “delivered” to the anomeric position of the donor resulting in a facially preferential glycosidic bond formation that is syn-selective with respect to the picoloyl protecting group.
Scheme 1.
Mechanistic depiction of the HAD glycosylation method.
The HAD reaction has successfully been applied to α-glucosylation using 4-O-Pico donor8 and its utility was demonstrated by the synthesis of linear and branched α-glucans.9 Also mannosylation with the use of either 3- or 6-O-Pico donors proceeded with high β-stereoselectivity,10 which was demonstrated by the sinthesis of a β-linked mannan at room temperature.10 Further expansion of the HAD led to the development of new activation conditions,11 protecting groups,12,13 and glycosyl donors with switchable stereoselectivity.14,15 Mong and co-workers applied 6-O-picoloyl-2-deoxy glycosyl donors to stereoselective synthesis of β-glycosides.16 Yang and co-workers investigated the synthesis of β-D- and β-L-arabinofuranosides,12 whereas De Meo17 and Tsai18 investigated the effect of picoloyl substituents on sialylations.
β-Glucosidic bonds are common glycosidic linkages that are often present in natural products19 and various microbial, plant, and fungal glycan sequences.20,21 Chemically, β-glucosides are typically formed with high stereoselectivity from glycosyl donors functionalized with an acyl protecting group at the C-2 position capable of the neighboring group participation. Upon activation, these donors form the bicyclic acyloxonium ion intermediate that hinders the nucleophilic attack from the bottom face of the ring22. Despite this method’s popularity it is prone to byproduct formation, such as an 1,2-O-orthoester,23 and regioselective selective functionalization of the C-2 position can complicate the synthesis of glycosyl donors24. In contrast, the HAD method has been shown to form β-glucosides utilizing donors functionalized at the primary C-6 position, offering enhanced synthetic flexibility. However, the preliminary attempts were limited to glycosylation of primary hydroxyl of glucosyl acceptor.8 To broaden the scope of the HAD-assisted synthesis of β-linked glucosides and disaccharides reported herein is the investigation of thioglucoside donor 1. Compound 1 equipped with the 6-O-picoloyl protecting group has already been shown to perform HAD glycosylations with β-stereoselectively, and its synthesis is known.8
Results and Discussion
Previous glycosylations were performed in the presence of dimethyl(thiomethyl)sulfonium triflate (DMTST) and molecular sieves (4 Å) in 1,2-dichloroethane (1,2-DCE) both under regular (50 mM) and low (5 mM) concentration of donor 1. DMTST was added at −30 °C, and the reaction mixture was then allowed to warm to room temperature. Thus, under these reaction conditions that became standard for the HAD reactions, glycosylation of acceptor 225,26 with donor 1 proceeded smoothly and β-stereoselectively affording disaccharide 3 in 78-90% yield (entry 1, Table 1). This result was practically the same as that previously reported for this donor-acceptor combination.8 To expand upon these findings, the glycosylation of other common carbohydrate acceptors with donor 1 were examined and the key findings are summarized in Table 1. The primary acceptor 4 afforded the corresponding disaccharide 5 with respectable yields of 81-91% and complete stereoselectivity (entry 2). Very unexpectedly, the β-stereoselectivity was dramatically decreased when benzoylated primary acceptor 627 was glycosylated. The reaction was still fairly swift (1.5 h), and respectable yields for the synthesis of disaccharide 7 (82-92%) have been achieved, but the stereoselectivity was fairly low (α/β = 1/2.7-2.9, entry 3) in comparison to the results obtained with other primary acceptors (vide supra). This last result made us believe that the efficacy of the HAD reaction with donor 1 can be greatly dependent on the electronic properties of the glycosyl acceptor. Thus, with the electro-withdrawing substituents in acceptor 7, the electron density on the hydroxyl group is decreased in comparison to that of alkylated counterparts. As a result, the hydrogen-bond-donating properties of such electron-poor glycosyl acceptor are reduced and the picoloyl-assisted H-bond-mediated aglycone delivery becomes less prevalent reaction pathway.
Table 1.
Glycosylation of primary and secondary glycosyl acceptors with donor 1
![]() |
||||
|---|---|---|---|---|
| Entry | Acceptor (ROH) | Conc. of 1, time | Product | yield (α/β ratio) |
| 1 | ![]() |
5 mM, 2 h | ![]() |
78% (β-only) |
| 50 mM, 3 h | 90% (β-only) | |||
| 2 | ![]() |
5 mM, 1.5 h | ![]() |
91% (β-only) |
| 50 mM, 1.5 h | 81% (β-only) | |||
| 3 | ![]() |
5 mM, 1.5 h | ![]() |
82% (1/2.7) |
| 50 mM, 1.5 h | 92% (1/2.9) | |||
| 4 | ![]() |
5 mM, 24 h | ![]() |
42% (1/1.3) |
| 50 mM, 24 h | 48% (1/2.6) | |||
| 5 | ![]() |
5 mM, 24 h | ![]() |
49% (1/2.5) |
| 50 mM, 24 h | 43% (1/1.0) | |||
| 6 | ![]() |
5 mM, 24 h | ![]() |
37% (1/2.5) |
| 50 mM, 24 h | 31% (1/3.5) | |||
| 7 | ![]() |
5 mM, 24 h | ![]() |
38% (1/4.3) |
| 50 mM, 24 h | 31% (1/2.5) | |||
The less reactive, more sterically hindered secondary acceptors also proved to be problematic for the HAD reaction with donor 1. Poor yields and stereoselectivities, as well as long reaction times, were observed for acceptors 8,28 10,29 and 1230 (entries 4-6). An improvement in stereoselectivity was seen with the methylated secondary acceptor 1431 (entry 7). The reactivity of acceptor 14, however, was still fairly low leading to long reaction times and low yields. This last result made us believe that the stereoselectivity of the HAD reaction with donor 1 can be also dependent on the steric properties of the glycosyl acceptor. Thus, with the bulky benzyl substituents are present in the glycosyl acceptor, the accessibility of the secondary hydroxyl to form strong H-bonding with bulky picoloyl moiety of the donor is low in comparison to that of less hindered methylated (or primary) counterparts. As a result, the H-bond-donating properties of such hindered glycosyl acceptors are reduced and the picoloyl-assisted delivery becomes a less prevalent stereodirecting pathway. In an attempt to improve results with secondary acceptors, various reaction conditions were investigated in the glycosylation of donor 1 and secondary acceptor 10. Slightly improved selectivity was observed upon switching to the stronger promoter system of NIS/TfOH. The extended experimental data can be found in the supporting information.
These results were puzzling to us because previously investigated 4-O-Pico donor provided excellent syn-stereoselectivity for the synthesis of α-glucosides, which was practically independent on the nature of the glycosyl acceptor.8 On the other hand, the previously investigated 6-O-Pico mannosyl donor provided high syn-stereoselectivity for the synthesis of β-mannosides.8,10 To develop a convenient tool-kit for studying this controversial reaction, we turned our attention to glycosylation of small molecule acceptors that could serve a simplified albeit more easily tunable platform for studying possible electronic and steric effects on the outcome of the HAD reaction. The key results of this study performed under low concentration conditions (5 mM of glycosyl donor 1) are summarized in Table 2. Thus, all initially chosen primary aliphatic acceptors exhibited complete β-selectivity and the corresponding glycosides 16-19 we obtained in moderate-to-excellent yields (56-86%, entries 1-4). However, the stereoselectivity was diminished when 2,2,2-trichloroethanol was employed as the glycosyl acceptor. Thus, glycosylation of this more electron poor trichloro-substituted acceptor led to the formation of glycoside 20 in 77% with decreased selectivity α/β = 1/11.4 (entry 5) in comparison to the complete β-selectivity obtained with non-substituted ethanol (entry 1).
Table 2.
Glycosylation of small molecule acceptors to study the effect of steric and electronic factors on the HAD reaction
![]() | |||
|---|---|---|---|
| Entry | Acceptor | Time | Product (yield, α/β ratio) |
| 1 | ETOH | 0.5 h | ![]() |
| 2 | ![]() |
0.5 h | ![]() |
| 3 | ![]() |
0.5 h | ![]() |
| 4 | ![]() |
0.5 h | ![]() |
| 5 | Cl3CCH2OH | 0.5 h | ![]() |
| 6 | ![]() |
1.5 h | ![]() |
| 7 | 1.5 h | ![]() |
|
| 8 | ![]() |
1.5 h | ![]() |
| 9 | ![]() |
1.5 h | ![]() |
| 10 | ![]() |
1.5 h | ![]() |
| 11 | ![]() |
1.5 h | ![]() |
| 12 | 1.5 h | ![]() |
|
To investigate the role of steric factors on the stereoselectivity of these reactions, we chose a number of secondary and tertiary small molecule acceptors. The results of these glycosylations are summarized in entries 6-9 (Table 2). Thus, glycosides 21-24 were obtained in 56-78% yields, but the stereoselectivity was even lower than that obtained with 2,2,2-trichloroethanol (α/β = 1/1.0-4.0). To further investigate the effect of electronic factors on the stereoselectivity we chose a series of substituted phenol acceptors. Although stereoselectivity of glycosylation has been a well-documented problem with phenol acceptors,32 their scalable electronic properties made them attractive targets for our study. The results of these glycosylations are summarized in entries 10-12. Thus, glycosides 25-27 were obtained in 52-81% yields, but the stereoselectivity was modest (α/β = 1/1.2-5.5). Nevertheless, these results reveal a clear correlation between the electronics quantified by relative acidity of the aromatic acceptors and the stereoselectivity of their glycosylation. Specifically, as compared to unsubstituted phenol (pKa = 10) that afforded glycoside 25 (α/β = 1/4.7, entry 10), a slightly less acidic p-methoxyphenol (pKa = 10.2)33 showed a modest enhancement of stereoselectivity for the formation of glycoside 26 (α/β = 1/5.5, entry 11). Conversely, glycosylation of a much more acidic p-nitrophenol (pKa = 7.2)33 led to the formation of glycoside 27 with practically entire loss of stereoselectivity (α/β = 1/1.2, entry 12). In our opinion, this series of results clearly indicate the effect of the glycosyl acceptor on the stereoselectivity outcome of the HAD reaction
Conclusions
The glycosylations of the HAD-capable glycosyl donor 1 with various glycosyl acceptors were investigated. Primary acceptors, both carbohydrate and aliphatic alcohols afforded the glycosylation products with complete β-selectivity. Secondary acceptors and some primary acceptors with the reduced electron density of the hydroxyl group exhibited reduced stereoselectivity. Additionally, secondary carbohydrate acceptors had long reaction times and, in a number of cases, modest yields. Relieving some of the steric crowding in secondary acceptors, such as that noted with the methylated acceptor 14, led to a slightly improved stereoselectivity. The effect of electronic properties of glycosyl acceptors were further investigated by glycosylation of a series of phenolic acceptors. These reactions revealed a possible preliminary correlation between the electronics or acidity of the hydroxyl to the stereoselectivity observed. These findings are in agreement with the theory that hydrogen bonding is responsible for the observed selectivity in the HAD reactions. It has been well documented that both acidity and sterics of hydrogen-bond donors, the glycosyl acceptors in this case, can have a great influence on the hydrogen-bond strength.34 Interestingly, these factors do not seem important when employing 4-O-picoloyl donors that previously gave completely α-selective HAD-glycosylations with both primary and secondary acceptors.8
EXPERIMENTAL PART
General.
Column chromatography was performed on silica gel 60 (70-230 mesh), reactions were monitored by TLC on Kieselgel 60 F254. The compounds were detected by examination under UV light and by charring with 10% sulfuric acid in methanol. Solvents were removed under reduced pressure at <40 °C. CH2Cl2 and ClCH2CH2Cl (1,2-DCE) were distilled from CaH2 directly prior to application. Molecular sieves (4 Å) used for reactions were crushed and activated in vacuo at 390 °C for an initial 8 h and then for 2-3 h at 390 °C directly prior to application. Optical rotations were measured at ‘Jasco P-2000’ polarimeter. Unless noted otherwise, 1H NMR spectra were recorded in CDCl3 at 300 or 600 MHz, 13C NMR spectra were recorded in CDCl3 at 75 MHz.
The synthesis of disaccharides
General procedure.
Glycosyl donor 1 (0.05 mmol) and a glycosyl acceptor (0.038 mmol) were dried in high vacuum for 1 h at rt. Molecular sieves (4 Å, 60 mg or 150 mg for 50 mM or 5 mM reaction, respectively) and freshly distilled 1,2-dichloroethane (1.0 mL or 10.0 mL for 50 mM or 5 mM reaction, respectively) were added and the resulting mixture was stirred under argon for 1 h at rt. The mixture was cooled to −30 °C and DMTST (0.1 mmol) was added. The external cooling was removed, and the reaction mixture was allowed to warm up to rt gradually. Upon completion (see the time listed in Table 1), the solid was filtered off through a pad of Celite and rinsed successively with dichloromethane. The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 mL) and water (2 × 10 mL). The organic phase was separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate – hexanes gradient elution). Diastereomeric ratios were determined by comparison of the integral intensities of relevant signals in 1H NMR spectra.
Methyl O-(2,3,4-tri-O-benzyl-6-O-picoloyl-β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzyl-α-D-glucopyranoside (3) was obtained as a clear syrup from glycosyl donor 18 and acceptor 225,26 in 90% (β-only, 50 mM) and 78% (β-only, 5 mM) yield. The analytical data of the title compound were essentially the same as previously reported.8,35
O-(2,3,4-Tri-O-benzyl-6-O-picoloyl-β-D-glucopyranosyl)-(1→6)-1,2:3,4-di-O-isopropylidene-α-D-galactopyranose (5) was obtained as a yellow oil from glycosyl donor 1 and commercial acceptor 4 in 91% (β-only, 50 mM) and 70% (β-only, 5 mM) yield. Analytical data for 5: Rf = 0.44 (ethyl acetate/toluene, 2/3, v/v); [α]D22 -9.7 (c = 0.98, CHCl3); 1H NMR: δ, 1.30, 1.30, 1.42, 1.47 (4 s, 12H, 4 x CH3), 3.50 (dd, 1H, J2’,3’ = 8.3 Hz, H-2’), 3.64-3.75 (m, 4H, H-3’, 4’, 5’, 6a), 4.06-4.10 (m, 2H, H-5, 6b), 4.19 (dd, 1H, J3,4 = 8.0 Hz, H-3), 4.30 (dd, 1H, J2,3 = 4.8 Hz, H-2), 4.52 (d, 1H, J1’,2’ = 7.8 Hz, H-1’), 4.53-4.63 (m, 4H, H-4, 6a’, 6b’, ½ CH2Ph), 4.73 (d, 1H, 2J = 11.2 Hz, ½ CH2Ph), 4.80 (d, 1H, 2J = 10.8 Hz, ν CH2Ph), 4.88 (d, 1H, 2J = 10.8 Hz, ν CH2Ph), 4.99 (d, 1H, 2J = 10.8 Hz, ν CH2Ph), 5.06 (d, 1H, 2J = 11.2 Hz, ν CH2Ph), 5.55 (d, 1H, J1,2 = 5.0 Hz, H-1), 7.21-7.43 (m, 15H, aromatic), 7.45-7.48 (m, 1H, Pico), 7.81 (dd, 1H, J = 7.6 Hz, Pico), 8.04 (d, 1H, J = 7.8 Hz, Pico), 8.76 (d, 1H, J = 4.8 Hz) ppm; 13C NMR: δ, 24.4, 25.0, 26.0 (×2), 64.4, 67.4, 70.0, 70.4, 70.7, 71.4, 72.8, 74.4, 75.0, 75.8, 77.5, 81.6, 84.6, 96.3, 104.5, 108.5, 109.3, 125.3, 126.6, 127.5, 127.7, 127.9, 128.0, 128.2, 128.4, 128.6, 136.9, 137.7, 138.4, 138.6, 147.8, 150.0, 164.6 ppm; HR-FAB MS [M+H]+ calcd for C45H52NO12 798.3489, found 787.3538.
Methyl O-(2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranosyl)-(1→6)-2,3,4-tri-O-benzoyl-α-D-glucopyranoside (7) was obtained as a clear syrup from glycosyl donor 1 and acceptor 627 in 92% (α/β = 1/2.9, 50 mM) and 82% (α/β = 1/2.7, 5 mM) yield. Analytical data for 7: Rf = 0.63 (ethyl acetate/toluene, 2/3, v/v); selected 1H NMR data for α-7: δ, 3.53 (s, 3H, OCH3) ppm; selected 1H NMR data for β-7: δ, 3.42 (s, 3H, OCH3), 3.88 (dd, 1H, J5,6a = 7.2 Hz, J6a,6b = 11.1 Hz, H-6a), 4.38-4.43 (m, 1H, H-5), 4.77 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 4.85 (d, 1H, 2J = 10.8 Hz, ν CH2Ph), 4.94 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 5.02 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 5.16 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 5.52 (dd, 1H, J4,5 = 9.8 Hz, H-4), 6.20 (dd, 1H, J3,4 = 9.5 Hz, H-3), 8.80 (d, 1H, J = 4.6 Hz, Pico) ppm; selected 13C NMR data for β-7: δ, 55.6, 64.3, 68.8, 69.8, 70.4, 72.0, 72.9, 74.9, 75.0, 75.9, 77.4, 82.2, 84.5, 96.8, 104.0 ppm; HR-FAB MS [M+Na]+ calcd for C61H57NNaO15 1066.3626, found 1066.3641.
Methyl O-(2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranosyl)-(1→2)-3,4,6-tri-O-benzyl-α-D-glucopyranoside (9) was obtained as a clear syrup from glycosyl donor 1 and acceptor 828 in 48% (α/β = 1/1.3, 50 mM) and 42% (α/β = 1/2.6, 5 mM) yield. Analytical data for 9: Rf = 0.57 (ethyl acetate/toluene, 2/3, v/v); selected 1H NMR data for α-9: δ, 3.34 (s, 3H, OMe), 7.98 (dd, 1H, J = 7.8 Hz, Pico) ppm; selected 1H NMR data for the β-9: δ, 3.45 (s, 3H, OMe), 3.87 (dd, 1H, J2,3 = 9.9 Hz, H-2), 8.03 (d, 1H, J = 7.8 Hz, Pico) ppm; selected 13C NMR data for the anomeric region of α/β-9: δ, 93.9, 99.3, 99.5, 104.1 ppm; HR-FAB MS [M+H]+ calcd for C61H63NO12Na 1024.4248, found 1024.4246.
Methyl O-(2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranosyl)-(1→3)-2,4,6-tri-O-benzyl-α-D-glucopyranoside (11) was obtained as a clear syrup from glycosyl donor 1 and acceptor 1029 in 43% (α/β = 1/1.0, 50 mM) and 49% (α/β = 1/2.5, 5 mM) yield. Analytical data for 11: Rf = 0.24 (ethyl acetate/hexane, 2/3, v/v); selected 1H NMR data for α-11: δ, 3.31 (s, 3H, OCH3), 4.12 (dd, 1H, J,3’,4’ = 9.1 Hz, H-3’), 5.57 (d, 1H, J1’,2’ = 3.1 Hz, H-1’), 7.78 (dd, 1H, J = 7.8 Hz, Pico), 8.05 (d, 1H, J = 7.8 Hz, Pico), 8.74 (d, 1H, J = 4.8 Hz, Pico) ppm; selected 1H NMR data for β-11: δ, 3.29 (s, 3H, OCH3), 7.59 (dd, 1H, J = 7.8 Hz, Pico), 7.86 (d, 1H, J = 7.8 Hz, Pico), 8.70 (d, 1H, J = 3.9 Hz, Pico) ppm; selected 13C NMR data for the anomeric region of α/β-11: δ, 97.1, 97.3, 97.7, 102.7 ppm; HR-FAB MS [M+Na]+ calcd for C61H63NNaO12 1024.4248, found 1024.4246.
Methyl O-(2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranosyl)-(1→4)-2,3,6-tri-O-benzyl-α-D-glucopyranoside (13) was obtained as a clear syrup from glycosyl donor 1 and acceptor 1230 in 31% (α/β = 1/3.5, 50 mM) and 37% (α/β = 1/2.5, 5 mM) yield. Analytical data for 13: Rf= 0.30 (ethyl acetate/hexane, 2/3, v/v); selected 1H NMR data for α-13: δ, 3.38 (s, 3H, OCH3), 5.57 (d, 1H, J1’,2’ = 3.7 Hz, H-1’), 7.75 (dd, 1H, J = 7.8 Hz, Pico), 7.98 (d, 1H, J = 7.8 Hz, Pico) ppm; selected 1H NMR data for β-13: δ, 3.36 (s, 3H, OCH3), 5.05 (d, 1H, 2J = 11.3 Hz, ½ CH2Ph), 7.60 (dd, 1H, J = 7.6 Hz, Pico), 7.85 (d, 1H, J = 7.8 Hz, Pico) ppm; selected 13C NMR data for the anomeric region of α/β-13: δ, 96.5, 97.9, 98.5, 102.7 ppm; HR-FAB MS [M+Na]+ calcd for C61H63NNaO12 1024.4248, found 1024.4246.
Methyl O-(2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranosyl)-(1→4)-2,3,6-tri-O-methyl-α-D-glucopyranoside (15) was obtained as a clear syrup from glycosyl donor 1 and acceptor 1431 in 31% (α/β = 1/2.5, 50 mM) and 38% (α/β = 1/4.3, 5 mM) yield. Analytical data for α-15: Rf = 0.38 (ethyl acetate/dichloromethane, 1/1, v/v); [α]D22 93.4 (c = 0.88, CHCl3); 1H NMR: δ, 3.27 (dd, 1H, J2,3 = 9.5 Hz, H-2), 3.33, 3.40 (2 s, 6H, 2 × OCH3), 3.47-3.50 (m, 7H, H-6b, 2 × OCH3), 3.62 (dd, 1H, J2’,3’ = 9.8 Hz, H-2’), 3.69 (dd, 1H, J4’,5’ = 9.3 Hz, H-4’), 3.74 (dd, 1H, J3,4 = 9.1 Hz, H-3), 3.98-4.01 (m, 2H, H-5, 6a), 3.90-3.92 (m, 1H, H-5’), 3.95 (dd, 1H, J4,5 = 9.4 Hz, H-4), 4.00 (dd, 1H, J3’,4’ = 9.2 Hz, H-3’), 4.53 (dd, 1H, J6a’6b’ = 11.8 Hz, H-6a’), 4.62-4.64 (m, 2H, H-6a’, ½ CH2Ph), 4.74 (d, 1H, 2J = 11.7 Hz, ½ CH2Ph), 4.83 (d, 1H, 2J = 11.7 Hz, ½ CH2Ph), 4.85 (d, 1H, J1,2 = 3.5 Hz, H-1), 4.89 (d, 1H, 2J = 11.1 Hz, ½ CH2Ph), 4.97 (d, 1H, 2J = 10.5 Hz, ½ CH2Ph), 5.70 (d, 1H, J1’,2’ = 3.5 Hz, H-1’), 7.17-7.37 (m, 15H, aromatic), 7.44-7.45 (m, 1H, Pico), 7.79 (dd, 1H, J = 7.7 Hz, Pico), 8.01 (d, 1H, J = 7.8 Hz, Pico), 8.75 (d, 1H, J = 4.6 Hz, Pico) ppm; 13C NMR: δ, 55.1, 58.7, 59.0, 60.1, 64.0, 69.0, 69.2, 70.6, 70.8, 73.2, 75.0, 75.9, 77.1, 79.9, 82.0, 82.1, 83.4, 95.9, 97.1, 125.2, 126.8, 127.8 (× 2), 127.9, 128.0 (× 4), 128.1 (× 2), (× 2), 128.4 (× 2), 128.5 (× 3), 136.8 (× 2), 137.8, 138.4, 147.7, 150.1 (× 2), 164.6 ppm. Analytical data for β-15: Rf= 0.15 (ethyl acetate/dichloromethane, 1/1, v/v); [α]D22 57.6 (c = 0.74, CHCl3); 1H NMR: δ, 3.09 (dd, 1H, J2,3 = 9.6 Hz, H-2), 3.26-3.37 (2 s, 6H, 2 × OCH3), 3.41-3.47 (m, 10H, H-2’, 3, 5, 6a, 2 × OCH3), 3.54-3.56 (m, 1H, H-6b), 3.63-3.73 (m, 4H, H-3’, 4, 4’, 5’), 4.45 (d, IH, J1’,2’ = 7.8 Hz, H-1’), 4.61-4.63 (m, 3H, H-6a’, 6b’, ½ CH2Ph), 4.76 (d, 1H, J1,2 = 3.6 Hz, H-1), 4.80 (d, 1H, 2J = 11.4 Hz, ½ CH2Ph), 4.83 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.86 (d, 2H, 2J = 11.1 Hz, ½ CH2Ph), 4.94 (d, 1H, 2J = 10.7 Hz, ½ CH2Ph), 7.19-7.33 (m, 15H, aromatics), 7.44-7.45 (m, 1H, Pico), 7.78 (dd, 1H, J = 7.7 Hz, Pico), 8.03 (d, 1H, J = 7.9 Hz, Pico), 8.75 (d, 1H, J = 4.5 Hz, Pico) ppm; 13C NMR: δ, 29.7, 55.3, 58.9, 59.3, 60.2, 64.1, 69.6, 70.0, 72.6, 75.0, 75.1, 75.9, 77.4, 77.7, 80.6, 81.1, 82.6, 85.2, 97.7, 102.9, 125.2, 126.8, 127.6, 127.7 (× 2), 127.8 (× 3), 127.9, 128.1 (× 2), 128.3 (× 2), 128.4 (× 2), 128.5 (× 2), 136.8, 137.6, 138.2, 147.8, 150.0 (× 2), 164.5 ppm; HR-FAB MS [M+H]+ calcd for C43H51NNaO12 796.3308, found 796.3341.
The synthesis of glycosides
General procedure.
Glycosyl donor 1 (0.05 mmol) was dried in high vacuum for 1 h at rt. Molecular sieves (4 Å, 150 mg), freshly distilled 1,2-dichloroethane (10.0 mL), and an aliphatic or aromatic glycosyl acceptor (0.038 mmol) were added and the resulting mixture was stirred under argon for 1 h at rt. The mixture was cooled to −30 °C and DMTST (0.1 mmol) was added. The external cooling was removed, and the reaction mixture was allowed to warm up to rt gradually. Upon completion (see the time listed in Table 2), the solid was filtered off through a pad of Celite and rinsed successively with dichloromethane. The combined filtrate (~30 mL) was washed with sat. aq. NaHCO3 (10 mL) and water (2 × 10 mL). The organic phase was separated, dried with magnesium sulfate, and concentrated in vacuo. The residue was purified by column chromatography on silica gel (ethyl acetate – hexanes gradient elution). Diastereomeric ratios were determined by comparison of the integral intensities of relevant signals in 1H NMR spectra.
Ethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-β-D-glucopyranoside (16) obtained as a clear syrup from glycosyl donor 1 and freshly distilled ethanol in 86% yield (β-only). Analytical data for 16: Rf= 0.21 (ethyl acetate/hexane, 2/3, v/v); [α]D22 30.4 (c = 0.41, CHCl3); 1H NMR: δ, 1.18 (t, 3H, OCH2CH3), 3.51 (dd, 1H, J2,3 = 8.1 Hz, H-2), 3.51-3.67 (m, 4H, H-3, 4, 5, ½ CH2CH3), 3.83-3.93 if this is symmetrical, needs just the middle ppm value (m, 1H, ½ CH2CH3), 4.38 (d, 1H, J1,2 = 7.8 Hz, H-1), 4.49 (dd, 1H, J5,6a = 4.9 Hz, J6a,6b = 10.9 Hz, H-6a), 4.54-4.59 (m, 2H, H-6b, ½ CH2Ph), 4.66 (d, 1H, 2J = 11.0 Hz, ½ CH2Ph), 4.73 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.82 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.90 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 7.14-7.30 (m, 15H, aromatic), 7.37-7.42 (m, 1H, Pico), 7.74 (dd, 1H, J = 7.7 Hz, Pico), 7.98 (d, 1H, J = 7.8 Hz, Pico), 8.70 (d, 1H, J = 4.0 Hz, Pico) ppm; 13C NMR: δ, 15.3, 64.5, 65.8, 72.8, 74.9, 75.1, 75.9, 77.6, 82.2, 84.7, 103.5, 125.2, 126.9, 127.7, 127.8, 127.9, 128.0, 128.1, 128.2, 128.4, 128.5 (× 3), 136.9, 138.4, 150.0 ppm; HR-FAB MS [M+Na]+ calcd for C35H37NNaO7 606.2468, found 606.2468.
4-Azidobutyl 2,3,4-tri-O-benzyl-6-O-picoloyl-β-D-glucopyranoside (17) was obtained as a colorless syrup from glycosyl donor 1 and 4-azido-1-butanol36,37 in 73% yield (β-only). Analytical data for 17: Rf = 0.69 (ethyl acetate/toluene, 2/3, v/v); [α]D22 30.1 (c = 0.39, CHCl3); 1H NMR: δ, 1.62-1.71 (m, 4H, -CH2CH2-), 3.2-3.26 (m, 2H, -CH2N3), 3.45 (dd, 1H, J2,3 = 8.7 Hz, H-2), 3.52-3.55 (m, 1H, ½ -OCH2CH2-), 3.62 (dd, 1H, J4,5 = 9.1 Hz, H-4), 3.66-3.70 (m, 1H, H-5), 3.70 (dd, 1H, J3,4 = 8.9 Hz, H-3), 3.87-3.89 (m, 1H, ½ -OCH2CH2-), 4.41 (d, 1H, J1,2 = 7.8 Hz, H-1), 4.56 (dd, 1H, J5,6a = 5.2 Hz, J6a,6b = 11.9 Hz, H-6a), 4.62 (d, 2H, 2J = 11.1 Hz, H-6b, ½ CH2Ph), 4.73 (d, 1H, 2J = 11.1 Hz, ½ CH2Ph), 4.80 (d, 1H, 2J = 10.7 Hz, ½ CH2Ph), 4.89 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.91 (d, 1H, 2J = 11.1 Hz, ½ CH2Ph), 4.95 (d, 1H, 2J = 10.7 Hz, ½ CH2Ph), 7.22-7.36 (m, 15H, aromatic), 7.45-7.48 (m, 1H, Pico), 7.82 (dd, 1H, J = 7.7 Hz, Pico),8.04 (d, 1H, J = 7.7 Hz, Pico), 8.76 (d, 1H, J = 4.5 Hz, Pico) ppm; 13C NMR: δ, 25.6, 26.9, 51.1, 64.4, 69.2, 72.9, 74.9, 75.1, 75.9, 77.7, 82.2, 84.7, 103.5, 125.2, 126.9, 127.8 (½ 2), 128.0 (½ 5),(½ 2), 128.4 (½ 3), 128.5 (½ 6), 136.9, 137.6, 138.3, 147.7, 150.0 ppm; HR-FAB MS [M+Na]+ calcd for C37H40NNaO7 675.2795, found 675.2798.
8-Trityloxyoctyl 2,3,4-tri-O-benzyl-6-O-picoloyl-β-D-glucopyranoside (18) was obtained as a yellow syrup from glycosyl donor 1 and 8-trityloxy-1-octanol38 in 56% yield (β-only). Analytical data for 18: Rf= 0.56 (ethyl acetate/hexane, 2/3, v/v); [α]D22 26.2 (c = 0.42, CHCl3); 1H NMR: δ, 1.19-1.32 (m, 8H, 4 × C-CH2-C), 1.55-1.62 (m, 4H, 2 × C-CH2-C), 3.00 (t, 2H, CH2OTr), 3.47 (dd, 1H, J2,3 = 8.7 Hz, H-2), 3.47-3.50 (m, 1H, ½ C-1-OCH2-), 3.62 (dd, 1H, J4,5 = 9.4 Hz, H-4), 3.67-3.70 (m, 1H, H-5), 3.70 (dd, 1H, J3,4 = 8.9 Hz, H-3), 3.85-3.89 (m, 1H, ½ C-1-OCH2-), 4.42 (d, 1H, J1,2 = 7.8 Hz, H-1), 4.56 (dd, 1H, J5,6b = 5.1, J6a,6b = 11.8 Hz, H-6a), 4.61(d, 2H, 2J = 10.7 Hz, H-6b, ½ CH2Ph), 4.71 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.80 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.88 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.94 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.95 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 7.19-7.43 (m, 31H, aromatic), 7.78 (dd, 1H, J = 7.7 Hz, Pico), 8.03 (d, 1H, J = 7.8 Hz, Pico), 8.74 (d, 1H, J = 4.5 Hz, Pico) ppm; 13C NMR: δ, 26.1, 26.2, 29.3, 29.5, 29.7, 30.0, 63.6, 64.5, 70.3, 72.8, 74.8, 75.1, 75.9, 77.7, 82.2, 84.7, 103.6, 125.2, 126.8 (× 3), 126.9, 127.7 (× 8), 127.9, 128.0 (× 2), 128.1 (× 3), 128.4 (× 4), 128.5 (× 2), 128.7 (× 6), 136.9 (× 2), 137.7, 138.3, 144.5 (× 5), 147.8, 150.0 (× 2), 164.7 ppm; HR-FAB MS [M+Na]+ calcd for C60H63NNaO8 948.4452, found 948.4409.
Benzyl 2,3,4-tri-O-benzyl-6-O-picoloylβ-D-glucopyranoside (19) was obtained as a colorless syrup from glycosyl donor 1 and benzyl alcohol in 57% yield (β-only). Analytical data for 19: Rf = 0.28 (ethyl acetate/hexane, 2/3, v/v); [α]D22 8.3 (c = 0.99, CHCl3); 1H NMR: δ, 3.48 (dd, 1H, J2,3 = 8.2 Hz, H-2), 3.58-3.67 (m, 3H, H-3, 4, 5), 4.47 (d, 1H, J1,2 = 7.7 Hz, H-1), 4.55-4.58 (m, 3H, H-6a, 6b, ½ CH2Ph), 4.65 (d, 1H, 2J = 11.0 Hz, ½ CH2Ph), 4.72 (d, 1H, 2J = 10.7 Hz, ½ CH2Ph), 4.83 (d, 1H, 2J = 11.2 Hz, ½ CH2Ph), 4.85-4.91 (m, 3H, 1.5 × CH2Ph), 7.18-7.26 (m, 15H, aromatic), 7.39-7.42 (m, 1H, Pico), 7.75 (dd, 1H, J = 7.4 Hz, Pico), 8.00 (d, 1H, J = 7.8 Hz, Pico), 8.71 (d, 1H, J = 3.3 Hz, Pico) ppm; 13C NMR: δ, 64.4, 71.1, 72.9, 74.9, 75.0, 75.9, 77.6, 82.2, 84.7, 102.2, 125.2, 126.9, 127.7, 127.8, 127.9 (× 2), 128.0 (× 2), 128.1 (× 4), 128.2 (× 2), 128.4 (× 4), 128.5 (× 4), 136.9, 137.1, 137.6, 138.2, 138.3, 147.8, 150.1, 164.7 ppm; HR-FAB MS [M+Na]+ calcd for C40H39NNaO7 668.2625, found 668.2632.
2,2,2-Trichloroethyl 2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (20) was obtained as a clear syrup from glycosyl donor 1 and 2,2,2-trichloroethanol in 77% yield (α/β = 1/11.4). Analytical data for 20: Rf = 0.31 (ethyl acetate/hexane, 2/3, v/v); selected 1H NMR data for β-20: δ, 3.57-3.77 (m, 4H, H-2, 3, 4, 5), 4.17 (d, 1H, 2J = 11.9 Hz, ½ CH2CCl3), 4.43 (d, 1H, 2J = 11.9 Hz, ½ CH2CCl3), 4.60-4.83 (m, 6H, H-1, 6a, 6b, 3 × ½ CH2Ph,), 4.89 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 4.99 (d, 1H, 2J = 10.2 Hz, ½ CH2Ph), 5.11 (d, 1H, 2J = 10.6 Hz, ½ CH2Ph), 7.23-7.40 (m, 15H, aromatic), 7.47-7.51 (m, 1H, Pico), 7.84 (dd, 1H, J = 7.7 Hz, Pico), 8.04 (d, 1H, J = 7.7 Hz, Pico), 8.77-8.79 (m, 1H, Pico) ppm; selected 13C NMR data for β-20: δ, 62.9, 63.7, 72.7,74.6, 74.7, 75.5, 76.8, 80.1, 81.3, 83.9, 95.9, 103.4, 124.8, 126.6, 127.4 (× 2), 127.5 (× 3), 127.6, 127.7 (× 2), 128.0 (× 8), 136.5, 137.0, 137.5, 137.8, 147.2, 149.61, 164.2 ppm; HR-FAB MS [M+H]+ calcd for C35H35Cl3NO7 686.1478, found 686.1450.
Isopropyl 2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (21) was obtained as a clear syrup from glycosyl donor 1 and freshly distilled isopropanol in 77% yield (α/β = 1/3.6). Analytical data for 21: Rf= 0.60 (ethyl acetate/toluene, 2/3, v/v); selected 1H NMR data for α-21: δ, 1.15-1.16 (m, 6H, CH(CH3)2), 3.95 (sep, 1H, CH(CH3)2), 4.04-4.08 (m, 2H, H-3, 5), 5.02 (d, 1H, 2J = 10.5 Hz, ½ CH2Ph), 7.99 (d, 1H, J = 7.8 Hz, Pico) ppm; selected 1H NMR data for β-21: δ, 1.21-1.22 (m, 6H, CH(CH3)2), 3.45 (dd, 1H, J2,3 = 8.9 Hz, H-2), 3.95 (sep, 1H, CH(CH3)2), 4.49 (d, 1H, J1,2 = 7.8 Hz, H-1), 4.55 (dd, 1H, J5,6a = 5.4 Hz, J6a,6b = 11.6 Hz, H-6a), 4.70 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 4.79 (d, 1H, 2J = 10.6 Hz, ½ CH2Ph), 4.88 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 8.04 (d, 1H, J = 5.8 Hz, Pico) ppm; selected 13C NMR data for the sugar region of α/β-21: δ, 64.6, 68.6, 69.4, 72.8, 72.9, 73.2, 74.9, 75.0, 75.2, 75.9, 77.7, 77.8, 80.0, 82.1, 82.2, 84.8, 94.7, 102.3 ppm; HR-FAB MS [M+Na]+ calcd for C36H39NNaO7 597.2727, found 620.2625.
Cyclohexyl 2,3,4-Tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (22) was obtained as a clear syrup from glycosyl donor 1 and cyclohexanol in 63% yield (α/β = 1/2.0). Analytical data for 22: Rf= 0.45 (ethyl acetate/hexane, 2/3, v/v); selected 1H NMR data for α-22: δ, 4.06 (dd, 1H, J3,4 = 9.2 Hz, H-3), 4.12 (m, 1H, H-5), 8.01 (d, 1H, J = 7.7 Hz, Pico) ppm; selected 1H NMR data for β-22: δ, 3.48 (dd, 1H, J2,3 = 8.5 Hz, H-2), 3.68-3.71 (m, 2H, H-3, 5), 4.54 (d, 1H, J1,2 = 7.8 Hz, H-1), 4.71 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.79 (d, 1H, 2J = 10.8 Hz, ν CH2Ph), 4.88 (d,1H, 2J = 10.9 Hz, ½ CH2Ph), 8.05 (d, 1H, J = 7.6 Hz, Pico) ppm; selected 13C NMR data for the sugar region of α/β-22: δ, 64.4, 64.6, 68.7, 72.7, 73.0, 74.9, 75.0, 75.2, 75.9, 77.8, 77.9, 78.4, 80.0, 82.1, 82.2, 84.8, 94.6, 102.1 ppm; HR-FAB MS [M+Na]+ calcd for C39H43NNaO7 660.2937, found 660.2946.
t-Butyl 2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (23) was obtained as a clear syrup from glycosyl donor 1 and t-butanol in 78% yield (α/β = 1/1.1). Analytical data for 23: Rf= 0.31 (ethyl acetate/hexane, 2/3, v/v); [α]D22 70.1 (c = 0.96, CHCl3); selected 1H NMR data for α-23: δ, 3.61 (dd, 1H, J4,5 = 9.5 Hz, H-4), 4.07 (dd, 1H, J3,4 = 9.3 Hz, H-3), 4.20-4.22 (m, 1H, H-5), 5.13 (d, 1H, J1,2 = 3.4 Hz, H-1), 8.01 (d, 1H, J = 7.8 Hz, Pico) ppm; selected 1H NMR data for β-23: δ, 3.45 (dd, 1H, J2,3 = 8.5 Hz, H-2), 8.03 (d, 1H, J = 7.7 Hz, Pico) ppm; selected 13C NMR data for the sugar region of α/β-23: δ, 64.6, 64.8, 68.3, 72.7, 73.1, 75.0, 75.8, 78.1 (× 2), 82.0, 82.3, 85.1, 91.3, 97.8 ppm; HR-FAB MS [M+Na]+ calcd for C37H41NNaO7 634.2781, found 634.2771.
1-Adamantyl 2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (24) was obtained as a clear syrup from glycosyl donor 1 and 1-adamantanol in 56% yield (α/β = 1/10). Analytical data for 24: Rf = 0.69 (ethyl acetate/toluene, 2/3, v/v); selected 1H NMR data for α-24: δ, 4.07 (dd, 1H, J3,4 = 9.1 Hz, H-3), 4.24-4.27 (m, 1H, H-5), 5.24 (d, 1H, J1,2 = 3.6 Hz, H-1), 8.02 (d, 1H, J = 7.8 Hz, Pico) ppm; selected 1H NMR data for β-24: δ, 3.45 (dd, 1H, J2,3 = 8.8 Hz, H-2), 3.51 (dd, 1H, J4,5 = 9.4 Hz, H-4), 3.69 (dd, 1H, J3,4 = 9.0 Hz, H-3), 3.69-3.73 (m, 1H, H-5), 4.60 (d, 1H, 2J = 11.0 Hz, ½ CH2Ph), 4.77 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 4.88 (d, 1H, 2J = 11.0 Hz, ½ CH2Ph), 4.93 (d, 1H, 2J = 10.7 Hz, ½ CH2Ph), 4.99 (d, 1H, 2J = 10.9 Hz, ½ CH2Ph), 8.05 (d, 1H, J = 7.8 Hz, Pico) ppm; selected 13C NMR data for α-24: δ, 64.8, 72.6, 74.9, 75.4, 75.9, 78.2, 82.2, 85.1, 96.2 ppm; HR-FAB MS [M+Na]+ calcd for C43H47NNaO7 712.3250, found 712.3265.
Phenyl 2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (25) was obtained as a clear syrup from glycosyl donor 1 and phenol in 81% yield (α/β = 1/4.7). Analytical data for 25: Rf= 0.36 (ethyl acetate/hexane, 2/3, v/v); selected 1H NMR data for β-25: δ, 4.10-4.15 (m, 1H, H-5), 4.27 (dd, 1H, J3,4 = 9.8 Hz, H-3), 5.45 (d, 1H, J1,2 = 2.8 Hz, H-1), 8.75 (d, 1H, J = 5.0 Hz, Pico) ppm; selected 13C NMR data for the sugar region of α/β-25: δ, 64.4, 73.1, 75.1, 76.0, 77.3, 77.7, 82.0, 84.7, 95.0, 101.6 ppm; HR-FAB MS [M+Na]+ calcd for C39H37NO7Na 654.2467, found 654.2479.
p-Methoxyphenyl 2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (26) was obtained as a clear oil from glycosyl donor 1 and p-methoxyphenol in 63% yield (α/β = 1/5.5). Analytical data for 26: Rf= 0.24 (ethyl acetate/hexane, 2/3, v/v); selected 1H NMR data for α-26: δ, 4.17 (m, 1H, H-5), 4.25 (dd, 1H, J3,4 = 9.2 Hz, H-3), 5.34 (d, 1H, J1,2 = 3.4 Hz, H-1), 8.75 (d, 1H, J = 4.5 Hz, Pico) ppm; selected 1H NMR data for β-26: δ, 4.98 (d, 1H, 2J = 10.8 Hz, ½ CH2Ph), 5.07 (d, 1H, 2J = 10.8 Hz, ν CH2Ph), 7.82 (dd, 1H, J = 7.4 Hz, Pico), 8.03 (d, 1H, J = 7.8 Hz, Pico), 8.80 (d, 1H, J = 4.4 Hz, Pico) ppm; 13C NMR data for the anomeric region of α/β-26: δ, 95.9, 102.7 ppm; HR-FAB MS [M+Na]+ calcd for C40H39NO8Na 684.2573, found 684.2576.
p-Nitrophenyl 2,3,4-tri-O-benzyl-6-O-picoloyl-α/β-D-glucopyranoside (27) was obtained as a clear syrup from glycosyl donor 17 and p-nitrophenol in 52% yield (α/β = 1/1.2). Analytical data for 27: Rf= 0.30 (ethyl acetate/hexane, 2/3, v/v); selected 1H NMR data for α-27: δ, 3.76 (dd, 1H, J2,3 = 9.4 Hz, H-2), 4.22 (dd, 1H, J3,4 = 9.1 Hz, H-3), 5.40 (d, 1H, J1,2 = 3.6 Hz, H-1), 8.71 (d, 1H, J = 7.3 Hz, Pico) ppm; selected 1H NMR data for β-27: δ, 4.43 (dd, 1H, 2J = 11.7 Hz, H-6a), 5.07 (d, 1H, J1,2 = 10.6 Hz, H-1), 8.83 (d, 1H, J = 7.3 Hz, Pico) ppm; selected 13C NMR data for the sugar region of α/β-27: δ, 63.8, 64.1, 70.2, 73.5, 75.2, 75.3, 76.0, 76.2, 77.3, 79.6, 79.6, 81.6, 82.0, 84.6, 94.9, 100.4, ppm; HR-FAB MS [M+Na]+ calcd for C39H36N2NaO9 699.2319, found 699.2287.
Supplementary Material
Highlights.
The glycosylations of the HAD-capable glycosyl donor showed a great variation of the results depending on the nature of glycosyl acceptors used
Primary acceptors, both carbohydrate and aliphatic alcohols afforded the glycosylation products with complete β-selectivity.
Both steric and electronic factors may have a strong effect on the stereoselectivity of HAD glycosylations for the synthesis of β-glucosides
Acknowledgments
Funding Sources
This work was supported by grants from the National Institute of General Medical Sciences (GM120673) and the National Science Foundation (CHE-1800350).
Footnotes
Supporting Information. Additional experimental details, 1H and 13C NMR spectra for all new compounds have been supplied as the Supporting Information. This material is available free of charge via the Internet at http://pubs.acs.org.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- (1).Handbook of chemical glycosylation: advances in stereoselectivity and therapeutic relevance; Demchenko AV, Ed.; Wiley-VCH: Weinheim, Germany, 2008. [Google Scholar]
- (2).Das R; Mukhopadhyay B ChemOpen 2016, 5, 401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (3).Selective Glycosylations: Synthetic Methods and Catalysts; Bennett CS, Ed.; Wiley-VCH: Weinheim, 2017. [Google Scholar]
- (4).Crich D Acc. Chem. Res 2010, 43, 1144. [DOI] [PubMed] [Google Scholar]
- (5).Adero PO; Amarasekara H; Wen P; Bohé L; Crich D Chem. Rev 2018, in press. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).Nukada T; Berces A; Whitfield DM Carbohydr. Res 2002, 337, 765. [DOI] [PubMed] [Google Scholar]
- (7).Nigudkar SS; Demchenko AV Chem. Sci 2015, 6, 2687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (8).Yasomanee JP; Demchenko AV J. Am. Chem. Soc 2012, 134, 20097. [DOI] [PubMed] [Google Scholar]
- (9).Yasomanee JP; Demchenko AV Angew. Chem. Int. Ed 2014, 53, 10453. [DOI] [PubMed] [Google Scholar]
- (10).Pistorio SG; Yasomanee JP; Demchenko AV Org. Lett 2014, 16, 716. [DOI] [PubMed] [Google Scholar]
- (11).Yasomanee JP; Demchenko AV Chem. Eur. J 2015, 21, 6572. [DOI] [PubMed] [Google Scholar]
- (12).Liu Q-W; Bin H-C; Yang J-S Org. Lett 2013, 15, 3974. [DOI] [PubMed] [Google Scholar]
- (13).Visansirikul S; Yasomanee JP; Demchenko AV Russ. Chem. Bull 2015, 1107. [Google Scholar]
- (14).Kayastha AK; Jia XG; Yasomanee JP; Demchenko AV Org. Lett 2015, 17, 4448. [DOI] [PubMed] [Google Scholar]
- (15).Yasomanee JP; Parameswar AR; Pornsuriyasak P; Rath NP; Demchenko AV Org. Biomol. Chem 2016, 14, 3159. [DOI] [PubMed] [Google Scholar]
- (16).Ruei J-H; Venukumar P; Ingle AB; Mong K-KT Chem. Commun 2015, 51, 5394. [DOI] [PubMed] [Google Scholar]
- (17).Escopy S; Geringer SA; De Meo C Org. Lett 2017, 19, 2638. [DOI] [PubMed] [Google Scholar]
- (18).Wu YF; Tsai YF Org. Lett 2017, 19, 4171. [DOI] [PubMed] [Google Scholar]
- (19).Yang Y; Zhang X; Yu B Nat. Prod. Rep 2015, 32, 1331. [DOI] [PubMed] [Google Scholar]
- (20).BeMiller JN In Glycoscience: Chemistry and Chemical Biology; Fraser-Reid B, Tatsuta K, Thiem J, Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 2, p 1435. [Google Scholar]
- (21).Robyt JE In Glycoscience: Chemistry and Chemical Biology; Fraser-Reid B, Tatsuta K, Thiem J, Eds.; Springer: Berlin - Heidelberg - New York, 2001; Vol. 1, p 75. [Google Scholar]
- (22).Goodman L Adv. Carbohydr. Chem. Biochem 1967, 22, 109. [DOI] [PubMed] [Google Scholar]
- (23).Bochkov AF; Zaikov GE Chemistry of the O-glycosidic bond: formation and cleavage; Pergamon Press: Oxford - New York - Toronto - Sydney - Paris - Frankfurt, 1979. [Google Scholar]
- (24).Lawandi J; Rocheleau S; Moitessier N Tetrahedron 2016, 72, 6283. [Google Scholar]
- (25).Kuester JM; Dyong I Justus Liebigs Ann. Chem 1975, 2179. [Google Scholar]
- (26).Ranade SC; Kaeothip S; Demchenko AV Org. Lett 2010, 12, 5628. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (27).Zhang F; Zhang W; Zhang Y; Curran DP; Liu GJ Org. Chem 2009, 74, 2594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (28).Sollogoub M; Das SK; Mallet J-M; Sinay P Comptes Rendus de l’ Academie des Sciences, Serie II 1999, 2, 441. [Google Scholar]
- (29).Koto S; Takebe Y; Zen S Bull. Chem. Soc. Jpn 1972, 45, 291. [Google Scholar]
- (30).Garegg PJ; Hultberg H Carbohydr. Res 1981, 93, C10. [DOI] [PubMed] [Google Scholar]
- (31).Liptak A; Jodal I; Nanasi P Carbohydr. Res 1975, 44, 1. [Google Scholar]
- (32).Lee YS; Rho ES; Min YK; Kim BT; Kim KH J. Carbohydr. Chem 2001, 20, 503. [Google Scholar]
- (33).Liptak MD; Gross KC; Seybold PG; Feldgus S; Shields GC J. Amer. Chem. Soc 2002, 124, 6421. [DOI] [PubMed] [Google Scholar]
- (34).Laurence C; Berthelot M Perspect. Drug Discov 2000, 18, 39. [Google Scholar]
- (35).Mannino MP; Yasomanee JP; Demchenko AV; Patteti V In Carbohydrate Chemistry: Proven Synthetic Methods; Murphy P, Vogel P, Eds.; CRC Press: Boca Raton - London - New York, 2017; Vol. 4, p 3. [Google Scholar]
- (36).Alewood PF; Benn M; Reinfried R Can. J. Chem 1974, 52, 4083. [Google Scholar]
- (37).Khiar N; Werner S; Mallouk S; Lieder F; Alcudia A; Fernandez IJ Org. Chem 2009, 74, 6002. [DOI] [PubMed] [Google Scholar]
- (38).Kang J-H; Kim SY; Lee J; Marquez VE; Lewin NE; Pearce LV; Blumberg PM J. Med. Chem 2004, 47, 4000. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.





































